Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v15-FR Version v8-EN
Language French English
Date Updated 2021-02-23 2020-11-03
Drug Identification Number 00614254 00614254
Brand name TOBREX TOBREX
Common or Proper name TOBREX OINTMENT 3.5 G TOBREX OINTMENT 3.5 G
Company Name NOVARTIS PHARMACEUTICALS CANADA INC NOVARTIS PHARMACEUTICALS CANADA INC
Ingredients TOBRAMYCIN TOBRAMYCIN
Strength(s) 0.3% 0.3%
Dosage form(s) OINTMENT OINTMENT
Route of administration OPHTHALMIC OPHTHALMIC OPHTHALMIC OPHTHALMIC
Packaging size 3.5 G 3.5 G
ATC code S01AA S01AA
ATC description ANTIINFECTIVES ANTIINFECTIVES
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2020-09-14 2020-09-14
Actual start date 2020-09-10 2020-09-10
Estimated end date 2021-03-15 2021-01-13
Actual end date 2021-02-23
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments